Stockreport

Halozyme granted injunction in Germany barring Merck's subcutaneous Keytruda [Seeking Alpha]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF the subcutaneous version of its cancer treatment Keytruda (pembrolizumab) in Germany. Halozyme previously filed a patent infringement lawsuit against Merck arguing tha [Read more]